Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 5
2004 8
2005 4
2006 6
2007 10
2008 5
2009 4
2010 2
2011 4
2012 5
2013 7
2014 7
2015 6
2016 6
2017 10
2018 8
2019 10
2020 11
2021 3
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
aMAP Score and Its Combination With Liver Stiffness Measurement Accurately Assess Liver Fibrosis in Chronic Hepatitis B Patients.
Fan R, Li G, Yu N, Chang X, Arshad T, Liu WY, Chen Y, Wong GL, Jiang Y, Liang X, Chen Y, Jin XZ, Dong Z, Leung HH, Wang XD, Zeng Z, Yip TC, Xie Q, Tan D, You S, Ji D, Zhao J, Sanyal AJ, Sun J, Zheng MH, Wong VW, Yang Y, Hou J. Fan R, et al. Among authors: tan d. Clin Gastroenterol Hepatol. 2023 Nov;21(12):3070-3079.e13. doi: 10.1016/j.cgh.2023.03.005. Epub 2023 Mar 17. Clin Gastroenterol Hepatol. 2023. PMID: 36933605
Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial.
Wei L, Zhao T, Zhang J, Mao Q, Gong G, Sun Y, Chen Y, Wang M, Tan D, Gong Z, Li B, Niu J, Li S, Gong H, Zou L, Zhou W, Jia Z, Tang Y, Fei L, Hu Y, Shang X, Han J, Zhang B, Wu Y. Wei L, et al. Among authors: tan d. Hepatology. 2022 Jan;75(1):182-195. doi: 10.1002/hep.32109. Epub 2021 Dec 8. Hepatology. 2022. PMID: 34396571 Clinical Trial.
Long-term outcomes in Chinese patients with chronic hepatitis B receiving nucleoside/nucleotide analogue therapy in real-world clinical practice: 5-year results from the EVOLVE study.
Jia J, Shang J, Tang H, Jiang J, Ning Q, Dou X, Zhang S, Zhang M, Han T, Tan D, Zhou X, Chen G, Sheng J, Su Z, Chen H, Dai E, Ye Y, Guo Y, Shen Y, Yuan J, Wei Z, Zhu S; EVOLVE Study Group. Jia J, et al. Among authors: tan d. Antivir Ther. 2020;25(6):293-304. doi: 10.3851/IMP3372. Antivir Ther. 2020. PMID: 33090970
117 results